scPharmaceuticals Inc. Quarterly Depreciation in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
scPharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from Q1 2017 to Q3 2024.
  • scPharmaceuticals Inc. Depreciation for the quarter ending September 30, 2024 was $5K, a 16.7% decline year-over-year.
  • scPharmaceuticals Inc. Depreciation for the twelve months ending September 30, 2024 was $22K, a 18.5% decline year-over-year.
  • scPharmaceuticals Inc. annual Depreciation for 2023 was $24K, a 35.1% decline from 2022.
  • scPharmaceuticals Inc. annual Depreciation for 2022 was $37K, a 8.82% increase from 2021.
  • scPharmaceuticals Inc. annual Depreciation for 2021 was $34K, unchanged from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $22K $5K -$1K -16.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $23K $5K -$1K -16.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $24K $6K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $24K $6K -$3K -33.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $27K $6K -$4K -40% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $31K $6K -$3K -33.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $34K $6K -$3K -33.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $37K $9K +$1K +12.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $36K $10K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $36K $9K +$1K +12.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $35K $9K +$1K +12.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $34K $8K -$1K -11.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $35K $10K +$2K +25% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $33K $8K -$1K -11.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $34K $8K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $34K $9K +$1K +12.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 $33K $8K -$2K -20% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $35K $9K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $35K $8K -$2K -20% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $37K $8K -$1K -11.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 $38K $10K $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $38K $9K $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $38K $10K $0 0% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $38K $9K $0 0% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 $38K $10K +$5K +100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $33K $9K +$8K +800% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $25K $10K +$8K +400% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $17K $9K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-21
Q3 2017 $5K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $1K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $2K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.